VANI Vivani Medical, Inc.

NASDAQ
$1.40

Vivani Medical, Inc. (VANI) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $0.07 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.5% since its last earnings release on August 13, 2026.

Vivani Medical Beat Consensus Estimates
Thursday, August 13, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.07)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.40

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Vivani Medical, Inc.

Vivani Medical Inc. is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The Company leverages proprietary technologies to develop and commercialize drug and device implants that treat patients with chronic diseases. Vivani Medical Inc., formerly known as Second Sight Medical Inc., is based in EMERYVILLE, Calif.

Sector

Healthcare

Industry

Drug Delivery